149 related articles for article (PubMed ID: 15792118)
1. Combined application of RT-PCR and immunohistochemistry on paraffin embedded sentinel lymph nodes of prostate cancer patients.
Haas CJ; Wagner T; Wawroschek F; Arnholdt H
Pathol Res Pract; 2005; 200(11-12):763-70. PubMed ID: 15792118
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
[TBL] [Abstract][Full Text] [Related]
3. Micrometastases detected by cytokeratin 19 expression in sentinel lymph nodes of patients with early-stage cervical cancer.
Wang HY; Sun JM; Lu HF; Shi DR; Ou ZL; Ren YL; Fu SQ
Int J Gynecol Cancer; 2006; 16(2):643-8. PubMed ID: 16681740
[TBL] [Abstract][Full Text] [Related]
4. Tyrosinase RT-PCR as a supplement to histology for detecting melanoma and nevus cells in paraffin sections of sentinel lymph nodes.
Starz H; Haas CJ; Schulz GM; Balda BR
Mod Pathol; 2003 Sep; 16(9):920-9. PubMed ID: 13679456
[TBL] [Abstract][Full Text] [Related]
5. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction.
Kusuda Y; Miyake H; Kurahashi T; Fujisawa M
Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Shariat SF; Roudier MP; Wilcox GE; Kattan MW; Scardino PT; Vessella RL; Erdamar S; Nguyen C; Wheeler TM; Slawin KM
Cancer Res; 2003 Aug; 63(15):4662-70. PubMed ID: 12907647
[TBL] [Abstract][Full Text] [Related]
7. Detection of pelvic lymph node micrometastasis by real-time reverse transcriptase polymerase chain reaction in prostate cancer patients after hormonal therapy.
Liu DY; Xia WM; Tang Q; Wang J; Wang MW; Wang Y; Wang SJ; Ye YF; Zhou WL; Shao Y
J Cancer Res Clin Oncol; 2014 Feb; 140(2):235-41. PubMed ID: 24292502
[TBL] [Abstract][Full Text] [Related]
8. Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer.
Ferrari AC; Stone NN; Eyler JN; Gao M; Mandeli J; Unger P; Gallagher RE; Stock R
J Natl Cancer Inst; 1997 Oct; 89(20):1498-504. PubMed ID: 9337346
[TBL] [Abstract][Full Text] [Related]
9. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.
Kammula US; Ghossein R; Bhattacharya S; Coit DG
J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222
[TBL] [Abstract][Full Text] [Related]
10. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay.
Palmieri G; Ascierto PA; Cossu A; Mozzillo N; Motti ML; Satriano SM; Botti G; Caracò C; Celentano E; Satriano RA; Lissia A; Tanda F; Pirastu M; Castello G;
J Clin Oncol; 2001 Mar; 19(5):1437-43. PubMed ID: 11230489
[TBL] [Abstract][Full Text] [Related]
11. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2000 Apr; 163(4):1183-8. PubMed ID: 10737491
[TBL] [Abstract][Full Text] [Related]
12. Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy.
Potter SR; Mangold LA; Shue MJ; Taylor DC; Lecksell KL; Epstein JI; Walsh PC; Partin AW
Cancer; 2000 Dec; 89(12):2577-86. PubMed ID: 11135219
[TBL] [Abstract][Full Text] [Related]
13. Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 years.
Schostak M; Krause H; Miller K; Schrader M; Kempkensteffen C; Kollermann J
BJU Int; 2007 Jun; 99(6):1409-14. PubMed ID: 17428244
[TBL] [Abstract][Full Text] [Related]
14. Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR.
Miyake H; Hara I; Kurahashi T; Inoue TA; Eto H; Fujisawa M
Clin Cancer Res; 2007 Feb; 13(4):1192-7. PubMed ID: 17317829
[TBL] [Abstract][Full Text] [Related]
15. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
[TBL] [Abstract][Full Text] [Related]
16. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
17. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction.
Deguchi T; Doi T; Ehara H; Ito S; Takahashi Y; Nishino Y; Fujihiro S; Kawamura T; Komeda H; Horie M
Cancer Res; 1993 Nov; 53(22):5350-4. PubMed ID: 7693338
[TBL] [Abstract][Full Text] [Related]
18. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
19. Increased detection of metastatic melanoma in pediatric sentinel lymph node biopsies using RT-PCR on paraffin-embedded tissue.
Somers GR; Chilton-MacNeill S; Zheng K; Stuart M; Pappo A; Zielenska M; Thorner PS
Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):365-70. PubMed ID: 20571343
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Kristiansen I; Stephan C; Jung K; Dietel M; Rieger A; Tolkach Y; Kristiansen G
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
